EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment

Yuting Zhang, Aoxue Zhong, Juan Min, Haibin Tu, Yanbing Cao, Jinghao Fu, Yonghao Li, Xiaolong Liu iD, Yong Yang, Jianmin Wang, Jingfeng Liu, Ming Wu iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.3c18140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Yuting Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Medical Innovation Project of Fujian Province, Scientific Foundation of Fujian Province, Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMiceAnimalsHumansImmune Checkpoint InhibitorsBiomimeticsImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

advanced HCC treatmentantiangiogenesiscell membrane overexpressing PD-1immune checkpoint blockadepoly(ethylene glycol)-poly(β-amino esters)

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, P. R. China.
  • The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.
  • Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, P. R. China.
  • Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, P. R. China.

ORCID-Profile: Xiaolong Liu, Ming Wu

Förderung

  • Medical Innovation Project of Fujian Province
  • Scientific Foundation of Fujian Province
  • Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province
  • Scientific Foundation of Fuzhou Municipal Health Commission

Zitieren

APA

Zhang, Y., Zhong, A., Min, J., Tu, H., Cao, Y., Fu, J., Li, Y., Liu, X., Yang, Y., Wang, J., Liu, J., & Wu, M. (2024). Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c18140

Vancouver

Zhang Y, Zhong A, Min J, Tu H, Cao Y, Fu J, et al. Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.3c18140

BibTeX
@article{Zhang2024,
  author = {Zhang, Yuting and Zhong, Aoxue and Min, Juan and Tu, Haibin and Cao, Yanbing and Fu, Jinghao and Li, Yonghao and Liu, Xiaolong and Yang, Yong and Wang, Jianmin and Liu, Jingfeng and Wu, Ming},
  title = {Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.3c18140}
}
Kostenlos starten →